Dr
Claire
Irvine

Partner & Patent Attorney

London Office Oxford Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 794 706 5907
Email. [email protected]

Experience

From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunology-related therapeutics, RNA therapeutics, synthetic biology and genetic diagnostics, including applications of bioinformatics. This continues as a partner of both the specialist HGF CRISPR and microbiome IP teams.

Claire has extensive experience of opposition and appeal proceedings at the European Patent Office, including both defending and opposing high profile patents which have attracted much interest beyond patent professionals. This has included patents from the early days of recombinant antibodies through to controversial patents arising from gene discovery and more recently, much publicised patents for gene-editing technologies.

Claire also has much experience of handling patent portfolios demanding inter-disciplinary input including in the fields of bioinformatics and medical and diagnostic devices. This has included much in the application of high-throughput nucleic acid sequencing technologies such as non-invasive foetal testing and cancer diagnostics.

As one of the most experienced patent partners’ of the life science team, Claire has the reputation of being able to apply creative thinking to turn around the most difficult IP problems. She has been responsible for building the IP portfolios of a number of companies and continues to enjoy the challenge of advising on freedom-to-operate and IP strategy.

Specialisms

  • Bioinformatics
  • Cell and gene therapy
  • Diagnostics
  • Gene editing technologies
  • Immunobiology
  • Microbiome
  • Personalised medicine

Industries

  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


MA

MA(Oxon) Biochemistry with supplemental chemical pharmacology

PHD

PhD St George's Hospital Medical School

Recognition

IAM Patent 1000 listed in 2021

Accompanying quotes: a " fearless warrior"; "Claire pays meticulous attention to detail and has superb technical and scientific knowledge; clients can concentrate on their own growth knowing their IP is in safe hands."

View recognition online

Publications

Getting your first filing right

View publication online

WIPR Publication 10 April 2019: Life Sciences: it pays to be wary over CRISPR

View publication online

LSIPR article June 2019: Russian Scientist pledges to make more CRISPR- edited babies

View publication online

LSIPR article March 2020: Broad Institute down (but not out) in the European Fight over CRISPR IP

View publication online

Regular provider of WIPR webinars on the CRISPR IP saga

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020

Speaker

Event details

Conferences: 2019

November 21st 2019

Life Sciences Patent Network Europe 2019

Speaker

Event details

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

April 25th 2019

Life Science Patent Network North America - Boston

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Lab-grown meat – not yet on the menu

It is now eight years since the first lab-grown burger was unveiled by a team of scientists at Maastricht University, but since then the path to market has been slow. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.